您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > GW 9662-d5
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
GW 9662-d5
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
GW 9662-d5图片
规格:98%
分子量:281.7
包装与价格:
包装价格(元)
500ug电议
1mg电议
5mg电议
10mg电议

产品介绍
A neuropeptide with diverse biological activities
货号:ajcx22598
CAS:N/A
分子式:C13H4ClD5N2O3
分子量:281.7
溶解度:DMF: 35 mg/ml,DMF:PBS(pH7.2) (1:2): >0.5 mg/ml,DMSO: 33 mg/ml,Ethanol: 2 mg/ml
纯度:98%
存储:Store at -20°C
库存:现货

Background:

The peroxisome proliferator-activated receptor γ (PPARγ) is the nuclear receptor responsible for transducing the therapeutic activity of the thiazolidinediones (TZDs). TZDs are a group of structurally related synthetic PPARγ agonists with antidiabetic actionsin vivo.1,2Rosiglitazone is a prototypical TZD and has served as a reference compound for this class.3There are many PPARγ agonists, including 15-deoxy-δ12,14-prostaglandin J2and azelaoyl PAF, which are naturally derived.4,5However, only a few antagonists have been reported.6GW 9662 blocks the PPARγ-induced differentiation of monocytes to osteoclasts by >90% at a dose of 0.1 µM.7It is therefore a much more potent antagonist than BADGE, which is another reported PPARγ antagonist.7


1.Willson, T.M., Cobb, J.E., Cowan, D.J., et al.The structure-activity relationship between peroxisome proliferator-activated receptor γ agonism and the antihyperglycemic activity of thiazolidinedionesJ. Med. Chem.39665-668(1996) 2.Maxey, K.M., Hessler, E., MacDonald, J., et al.The nature and composition of 15-deoxy-δ12,14-PGJ2Prostaglandins & Other Lipid Mediators6215-21(2000) 3.Wright, H.M., Clish, C.B., Mikami, T., et al.A synthetic antagonist for the peroxisome proliferator-activated receptor γ inhibits adipocyte differentiationThe Journal of Biological Chemisty2751873-1877(2000) 4.Lehmann, J.M., Moore, L.B., Smith-Oliver, T.A., et al.An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ)J. Biol. Chem.270(22)12953-12956(1995) 5.Cantello, B.C.C., Cawthorne, M.A., Cottam, G.P., et al.[[ω-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agentsJ. Med. Chem.373977-3985(1994) 6.Davies, S.S., Pontsler, A.V., Marathe, G.K., et al.Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor γ ligands and agonistsThe Journal of Biological Chemisty27616015-16023(2001) 7.Bendixen, A.C., Shevde, N.K., Dienger, K.M., et al.IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor γ1Proceedings of the National Academy of Sciences of the United States of America982443-2448(2001)